Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Weigert

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Cancer|July 11, 2006
Recommendations for the use of yttrium-90 ibritumomab tiuxetan in malignant lymphomaOliver Weigert, Tim Illidge, Wolfgang Hiddemann, et al.
Leukemia & Lymphoma|October 30, 2009
Mantle cell lymphoma: state-of-the-art management and future perspectiveOliver Weigert, Michael Unterhalt, Wolfgang Hiddemann, et al.
Haematologica|January 26, 2006
Current status and perspective of antibody therapy in follicular lymphomaChristian Buske, Oliver Weigert, Martin Dreyling, et al.
Current Oncology Reports|August 12, 2006
Investigational strategies in autologous stem cell transplantation for follicular lymphomaOliver Weigert, Martin Dreyling, Michael Unterhalt, et al.
British Journal of Haematology|November 1, 2006
Current management of follicular lymphomasWolfgang Hiddemann, Christian Buske, Martin Dreyling, et al.
Thrombosis and Haemostasis|May 29, 2010
Vincristine-loaded platelets for immune thrombocytopeniaOliver Weigert, Georg Wittmann, Stephanie Grützner, et al.
Thrombosis and Haemostasis|October 9, 2008
Successful salvage treatment of chronic refractory immune thrombocytopenia using a simplified method to generate vincristine-loaded plateletsOliver Weigert, Georg Wittmann, Stefanie Gruetzner, et al.
Annals of Hematology|January 11, 2012
The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphomaGrit Hutter, Malte Rieken, Alessandro Pastore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
Treatment strategies in follicular lymphomas: current status and future perspectivesWolfgang Hiddemann, Christian Buske, Martin Dreyling, et al.
Leukemia & Lymphoma|April 7, 2009
A novel regimen combining high dose cytarabine and bortezomib has activity in multiply relapsed and refractory mantle cell lymphoma - long-term results of a multicenter observation studyOliver Weigert, Eckhart Weidmann, Rudolf Mueck, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Cancer|July 11, 2006
Recommendations for the use of yttrium-90 ibritumomab tiuxetan in malignant lymphomaOliver Weigert, Tim Illidge, Wolfgang Hiddemann, et al.
Leukemia & Lymphoma|October 30, 2009
Mantle cell lymphoma: state-of-the-art management and future perspectiveOliver Weigert, Michael Unterhalt, Wolfgang Hiddemann, et al.
Haematologica|January 26, 2006
Current status and perspective of antibody therapy in follicular lymphomaChristian Buske, Oliver Weigert, Martin Dreyling, et al.
Current Oncology Reports|August 12, 2006
Investigational strategies in autologous stem cell transplantation for follicular lymphomaOliver Weigert, Martin Dreyling, Michael Unterhalt, et al.
British Journal of Haematology|November 1, 2006
Current management of follicular lymphomasWolfgang Hiddemann, Christian Buske, Martin Dreyling, et al.
Thrombosis and Haemostasis|May 29, 2010
Vincristine-loaded platelets for immune thrombocytopeniaOliver Weigert, Georg Wittmann, Stephanie Grützner, et al.
Thrombosis and Haemostasis|October 9, 2008
Successful salvage treatment of chronic refractory immune thrombocytopenia using a simplified method to generate vincristine-loaded plateletsOliver Weigert, Georg Wittmann, Stefanie Gruetzner, et al.
Annals of Hematology|January 11, 2012
The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphomaGrit Hutter, Malte Rieken, Alessandro Pastore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
Treatment strategies in follicular lymphomas: current status and future perspectivesWolfgang Hiddemann, Christian Buske, Martin Dreyling, et al.
Leukemia & Lymphoma|April 7, 2009
A novel regimen combining high dose cytarabine and bortezomib has activity in multiply relapsed and refractory mantle cell lymphoma - long-term results of a multicenter observation studyOliver Weigert, Eckhart Weidmann, Rudolf Mueck, et al.
Pageof 8